Fred Restaino

Fred Restaino is an experienced leader in clinical supply chain management, currently serving as Sr. Director of Clinical Supply Chain at POINT Biopharma, a subsidiary of Eli Lilly and Company, since December 2021. Previously, Fred held various roles including Director of Clinical Supply Management at Taysha Gene Therapies and Vice President of Operations at Clinical Supply Management, where operational functions were effectively managed to enhance growth and profitability. Additional experience encompasses positions such as Associate Director of Clinical Packaging and Labeling at Gilead Sciences and Senior Director of Clinical Supply Manufacturing and Packaging at Adolor Corporation. Fred began a career in clinical coordination and product development at STERLING HEALTH and MCNEIL PHARMACEUTICAL, following educational attainment of a Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy & Science.